TY - JOUR
T1 - Exploration of fulvic acid as a functional excipient in line with the regulatory requirement
AU - Gnananath, Kattamanchi
AU - Nataraj, Kalakonda Sri
AU - Rao, Battu Ganga
AU - Kumar, Kolli Prabhanjan
AU - Mahnashi, Mater H.
AU - Anwer, Md Khalid
AU - Umar, Ahmad
AU - Iqbal, Zeenat
AU - Mirza, Mohd Aamir
N1 - Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2020/8
Y1 - 2020/8
N2 - Fulvic acid, a humic substance often considered as a geopolymer, extracted from different natural resources like Shilajit, Peat, dissolved organic matters, etc. There are several reports of its pharmacological properties and its potential as pharmaceutical excipients. So, we have devised a project to strengthen its claim as a functional excipient. For the given project, lyophilized sample of a dietary supplement product (an aqueous solution of peat derived Fulvic acid) was used. The selected studies were typical for an excipient development like physicochemical properties, flow properties, compatibility with other excipient and stability studies, non-clinical safety studies (acute toxicity in mice whereas sub-acute toxicity in rats) and some functionality tests. We also suggest its ability to form co-crystal with natural phytochemicals. Our group has already reported its ability to enhance solubility and or bioavailability of different BCS class II drugs. Henceforth, we can propose that Fulvic acid appears a good candidate to be further explored as a functional excipient and should be evaluated as per the remaining recommendations of IPEC, USFDA, and USP.
AB - Fulvic acid, a humic substance often considered as a geopolymer, extracted from different natural resources like Shilajit, Peat, dissolved organic matters, etc. There are several reports of its pharmacological properties and its potential as pharmaceutical excipients. So, we have devised a project to strengthen its claim as a functional excipient. For the given project, lyophilized sample of a dietary supplement product (an aqueous solution of peat derived Fulvic acid) was used. The selected studies were typical for an excipient development like physicochemical properties, flow properties, compatibility with other excipient and stability studies, non-clinical safety studies (acute toxicity in mice whereas sub-acute toxicity in rats) and some functionality tests. We also suggest its ability to form co-crystal with natural phytochemicals. Our group has already reported its ability to enhance solubility and or bioavailability of different BCS class II drugs. Henceforth, we can propose that Fulvic acid appears a good candidate to be further explored as a functional excipient and should be evaluated as per the remaining recommendations of IPEC, USFDA, and USP.
KW - Dietary supplement
KW - Excipient compatibility
KW - Excipient stability
KW - Humic substances
KW - Pharmaceutical excipient
KW - Toxicity studies
UR - https://www.scopus.com/pages/publications/85084859468
U2 - 10.1016/j.envres.2020.109642
DO - 10.1016/j.envres.2020.109642
M3 - Article
C2 - 32445947
AN - SCOPUS:85084859468
SN - 0013-9351
VL - 187
JO - Environmental Research
JF - Environmental Research
M1 - 109642
ER -